相位分辨功能肺(PREFUL)MRI定量通气:在重度哮喘中的可行性与生理相关性
研究纳入41例重度哮喘患者和7例健康对照,比较PREFUL MRI衍生的通气缺陷百分比(VDP)与129Xe MRI VDP、肺功能及小气道病指标的相关性,并评估支气管扩张剂后的反应性。结果显示PREFUL VDP在哮喘患者中显著高于健康对照,且支气管扩张剂后显著下降,与气流阻塞及小气道功能障碍指标相关。
要点
- PREFUL VDP在重度哮喘患者中较健康对照显著升高,且支气管扩张剂后显著降低。
- PREFUL VDP与129Xe MRI VDP、FEV1%pred、FEV1/FVC及CT PRMfSAD等指标相关。
- PREFUL MRI可作为哮喘通气成像的生理相关且可及的结局指标。
核心结论
- PREFUL衍生的VDP在哮喘中对支气管扩张剂治疗有反应性,且与气流阻塞和小气道功能障碍指标相关,验证了其作为生理相关且可及的哮喘通气成像结局指标。
研究设计与样本
- 研究纳入41例重度哮喘成人和7例健康对照,同日完成自由呼吸1H MRI、129Xe MRI、肺量计和振荡仪检查;部分参与者(n=23)行胸部CT,另一部分哮喘参与者(n=19)在支气管扩张剂给药后重复1H MRI。
诊断标准与关键数值
- PREFUL VDP和129Xe MRI VDP均计算通气缺陷百分比;CT参数反应图确定功能性小气道病百分比(PRMfSAD)。
临床应用与阅片要点
- PREFUL VDP可用于哮喘患者通气缺陷的评估,并与常规肺功能及小气道病影像指标相关。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
英文原文(摘要)· 点击展开
RATIONALE AND OBJECTIVES: Emergent evidence in several respiratory diseases supports translational potential for Phase-Resolved Functional Lung (PREFUL) MRI to spatially quantify ventilation but its feasibility and physiological relevance have not been demonstrated in patients with asthma. This study compares PREFUL-derived ventilation defect percent (VDP) in severe asthma patients to healthy controls and measures its responsiveness to bronchodilator therapy and relation to established measures of airways disease.
MATERIALS AND METHODS: Forty-one adults with severe asthma and seven healthy controls performed same-day free-breathing 1H MRI, 129Xe MRI, spirometry, and oscillometry. A subset of participants (n = 23) performed chest CT and another subset of participants with asthma (n = 19) repeated 1H MRI following the administration of a bronchodilator. VDP was calculated for both PREFUL and 129Xe MRI. Additionally, the percent of functional small airways disease was determined from CT parametric response maps (PRMfSAD).
RESULTS: PREFUL VDP measured pre-bronchodilator (19.1% [7.4-43.3], p = 0.0002) and post-bronchodilator (16.9% [6.1-38.4], p = 0.0007) were significantly greater than that of healthy controls (7.5% [3.7-15.5]) and was significantly decreased post-bronchodilator (from 21.9% [10.1-36.9] to 16.9% [6.1-38.4], p = 0.0053). PREFUL VDP was correlated with spirometry (FEV1%pred: r = -0.46, p = 0.0023; FVC%pred: r = -0.35, p = 0.024, FEV1/FVC: r = -0.46, p = 0.0028), 129Xe MRI VDP (r = 0.39, p = 0.013), and metrics of small airway disease (CT PRMfSAD: r = 0.55, p = 0.021; Xrs5 Hz: r = -0.44, p = 0.0046, and AX: r = 0.32, p = 0.044).
CONCLUSION: PREFUL-derived VDP is responsive to bronchodilator therapy in asthma and is associated with measures of airflow obstruction and small airway dysfunction. These findings validate PREFUL VDP as a physiologically relevant and accessible ventilation imaging outcome measure in asthma.
引用
- Friedlander Y, Munidasa S, Thakar A, et al. Phase-Resolved Functional Lung (PREFUL) MRI to Quantify Ventilation: Feasibility and Physiological Relevance in Severe Asthma. Acad Radiol. 2024. PMID: 38378325. doi:10.1016/j.acra.2024.01.039
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。